Endocrine Society Alarmed by Texas Court Ruling Banning Mifepristone
April 11, 2023
April 11, 2023
WASHINGTON, April 11 (TNSgov) -- The Endocrine Society issued the following news release:
The Endocrine Society is deeply concerned about a Texas ruling that reverses the U.S. Food and Drug Administration's (FDA) approval of mifepristone, a drug used to treat Cushing's syndrome and to end pregnancy safely and effectively.
Last week, two conflicting federal court decisions in Texas and Washington state left access to mifepristone unclear for both the treatment of Cushing . . .
The Endocrine Society is deeply concerned about a Texas ruling that reverses the U.S. Food and Drug Administration's (FDA) approval of mifepristone, a drug used to treat Cushing's syndrome and to end pregnancy safely and effectively.
Last week, two conflicting federal court decisions in Texas and Washington state left access to mifepristone unclear for both the treatment of Cushing . . .